Advances in psychiatry and nuerology


ISSN 1234-8279

ISSN on-line 2449-9315 

 

As of July 2026, the journal's publisher is Wroclaw Medical University: https://ppn.umw.edu.pl/en/about/.

 

CiteScore 2025: 0.4

MNiSW: 20

Index Copernicus 2023: 90.54

Editorial panel
Submitting and reviewing works online
  • Home page
  • >
  • Archive
  • >
  • issue 2
  • >
  • Wpływ dożylnie podawanego metyloprednizolonu na parametry układu immunologicznego u chorych na stwardnienie rozsiane w trakcie rzutu

Archive 1995–2023

2002, volume 18, issue 2
Article

Wpływ dożylnie podawanego metyloprednizolonu na parametry układu immunologicznego u chorych na stwardnienie rozsiane w trakcie rzutu

Farmakoterapia w Psychiatrii i Neurologii, 2002, 2, 160-165
Summary

Glicocortycosteroids (GS) are the most common therapy of multiple sclerosis relapses, however mechanism of beneficial effect is not fully known. The aim of our study was to evaluate the changes of immunological profile (percentage of lymphocytes B, T and monocytes, and produced by this cells IL-6 and IL-8) during intravenous administration of Solu-Medrol. Using two-colour flow cytometry we have studied peripheral blood of 10 patients during exacerbation. We have observed statistically significant improvement of distbility measured with EDSS. Statistically significant increase in lymphocyte B percentage and decrease in suppressor T cells was also noted. Results of our study indicate that GS therapy affects not only clinical state but also parameters of peripheral blood immune profile.

You have added an item to your cart
Restore password
Shopping cart (0)
No products in your cart
Font size
Contrast
Underlined links